Update on the role of copanlisib in hematologic malignancies

Clinical research in hematologic malignancies is continually advancing with emerging concepts in therapy and evolving results from clinical protocols. Targeting of the PI3K pathway remains a valuable treatment across both hematologic and solid malignancies. There are currently four United States Foo...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Thuy, Jerel, David, Bryan, Locke J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040547/
https://www.ncbi.nlm.nih.gov/pubmed/33889376
http://dx.doi.org/10.1177/20406207211006027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040547/
https://www.ncbi.nlm.nih.gov/pubmed/33889376
http://dx.doi.org/10.1177/20406207211006027

Ejemplares similares